Welcome to Novo Nordisk in the United States

Patient Assistance - Growth Hormone Therapy

The Norditropin® Patient Access Program (PAP) reflects our commitment to social responsibility and our belief that a lack of financial resources should not stand in the way of necessary medical care. Through the Norditropin® PAP, those who qualify may receive free medicine.   Eligibility is based on financial resources, cost of living, size of household, and out-of-pocket medical costs.

The Norditropin® PAP is administered by NordiCare®, a comprehensive support program serving the needs of patients with growth hormone-related disorders and those who care for them  For more information on NordiCare®, please click here.

Upon approval, NordiCare® will ship a free 30-day supply of Norditropin® directly to the patient’s home.  Patients are eligible to remain in the program and receive monthly shipments as long as their financial and insurance situation does not enable them to afford Norditropin®. Every 6 months, a NordiCare® Case Manager will contact the patient to evaluate whether assistance is still required.   

Please contact your healthcare professional if you believe that you or someone you know should be considered for the Norditropin® PAP.

Get started with NordiCare® today. Call 1-888-NOVO-444.
If you are a healthcare professional and would like to learn how to put NordiCare® to work for your patients, click here.